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Phenotypic and functional analyses
of NK and NKT-like populations
during the early stages of
chikungunya infection
Subrat Thanapati, Rumki Das and Anuradha S. Tripathy *
Hepatitis Group, National Institute of Virology, Pune, India
The aim of this study was to characterize NK (CD56+CD3−) and NKT-like
cell (CD56+CD3+) responses early after chikungunya infection. Expression
profiling and functional analysis of T/NK/NKT-like cells were performed on
samples from 56 acute and 31 convalescent chikungunya patients and 56
control individuals. The percentages of NK cells were high in both patient
groups, whereas NKT-like cell percentages were high only in the convalescent
group. The percentages of NKp30+CD3−CD56+, NKp30+CD3+CD56+,
CD244+CD3−CD56+, and CD244+CD3+CD56+cells were high, whereas the
percentages of NKG2D+CD3−CD56+ and NKG2D+CD3+CD56+cells were low in
both patient groups. The percentages of NKp44+CD3−CD56+ cells were high in
both patient groups, whereas the percentages of NKp44+CD3+CD56+ cells were
higher in the acute group than in convalescent and control groups. The percentages
of NKp46+CD3−CD56+ cells were high in both patient groups. Higher percentages
of perforin+CD3−CD56+ and perforin+CD3+CD56+ cells were observed in acute and
convalescent patients, respectively. Higher cytotoxic activity was observed in acute
patients than in controls. IFN-γ expression on NK cells of convalescent patients and
on NKT-like cells of both patient groups was indicative of the regulatory role of NK
and NKT-like cells. Collectively, these data showed that higher expression of activating
receptors on NK/NKT-like cells and perforin+ NK cells in acute patients could be
responsible for increased cytotoxicity. The observed expression of perforin+ NK cells in
the acute phase and IFN-γ+ NKT-like cells in the subsequent convalescent stage showed
that NK/NKT-like cells mount an early and efficient response to chikungunya virus. Further
study of the molecular mechanisms that limit viral dissemination/establishment of chronic
disease will aid in understanding how NK/NKT-like cells control chikungunya infection.
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Introduction
Chikungunya (CHIK), a mosquito-borne viral disease caused
by the chikungunya virus (CHIKV), has caused global concern
since its re-emergence in several Asian and African countries
(Powers and Logue, 2007). CHIKV belongs to the Alphavirus
genus of the family Togaviridae, and is responsible for severe
rheumatic manifestations associated with inflammation and
musculoskeletal tissue destruction in humans (Suhrbier and La
Linn, 2004). CHIK epidemics have recently been reported in
new areas, such as North America and the Caribbean, where
the populations are naïve to this viral infection (Cassadou et al.,
2013; Leparc-Goffart et al., 2014; Van Bortel et al., 2014). Over 3
million suspected cases of CHIK have been recorded worldwide
till now (Seppa, 2015). In the absence of a specific treatment,
recent epidemics in previously naïve parts of the world have
elevated CHIK to a global health problem. The symptoms of
CHIK appear after an incubation period of 4−7 days following
CHIKV infection and mostly resolve within the acute phase.
Although, the acute phase lasts for approximately 2 weeks,
joint pain can persist for months or years following the initial
infection, which is the hallmark of chronic CHIKV infection
(Kelvin et al., 2011; Dupuis-Maguiraga et al., 2012). Recently
reported CHIK outbreaks have shown severe haemorrhagic and
neurologic manifestations, which could be attributed to host
immune response (Sissoko et al., 2008; Suhrbier et al., 2012). The
innate immune response plays a key role in virus suppression,
propagation, and dissemination before induction of the adaptive
immune response. Natural killer (NK) and natural killer T
(NKT) cells can kill target cells directly or interact with antigen-
presenting cells, T cells to produce cytokines, which have antiviral
activities and can trigger an adaptive immune response (Janeway
and Medzhitov, 2002). NKT-like cells are a subset of αβ T
cells that express NK activation receptors and also exhibit a
highly specialized effector memory phenotype (Peralbo et al.,
2007; Tang et al., 2013). The functional activity of NK/NKT-
like cells is regulated through their repertoire of activation
(NKG2C, NKG2D, NKp30, NKp44, and NKp46) and inhibitory
(CD158a, CD158b, KIR3DL1, and NKG2A) receptors, which
recognize ligands on the surface of target cells (Peralbo et al.,
2007; Watzl and Long, 2010; Das and Tripathy, 2014). Upon
activation, both NK and NKT-like cells produce inflammatory
cytokines, such as IFN-γ, and lyse target cells by exocytosis of
perforin and granzyme, leading to inhibition of viral replication
and enhancement of cytotoxicity against target cells (Biron and
Brossay, 2001; Janeway and Medzhitov, 2002; Peralbo et al.,
2007; Das and Tripathy, 2014). During the granule dependent
mechanism for killing of target cells, the lysosomal membrane
associated protein 1 (LAMP1/CD107a) becomes detectable on
the surface of NK cells and CTLs, indicating that CD107a
expression is a marker of degranulation (Kannan et al., 1996;
Bossi and Griffiths, 1999). NK cells contribution toward arthritis
in the Ross River virus infection has been reported by Aaskov
et al. (1987).
The higher levels of IFN-α and IL-12 observed in monocyte
cultures within 2 h of CHIKV infection suggested their possible
involvement in activating NK cells to increase antiviral activities
(Gherardi et al., 2003; Wang et al., 2009; Her et al., 2010). Studies
on humans and non-human primates have shown increased
NK cell numbers in the early stages of CHIKV infection and
suggested their participation in the early control of CHIKV
(Labadie et al., 2010; Watzl and Long, 2010). Petitdemange et al.
(2011) performed phenotypic and functional analyses of NK cells
from 25 patients in the early stages of acute CHIKV infection, and
showed engagement of a clonal expansion of CD94/NKG2C NK
cells that expressed receptors for HLA-C1 alleles, and correlated
with the viral load, suggesting that NK cells sense CHIKV from
the beginning of infection and may thus contribute to viral
clearance (Petitdemange et al., 2011). In contrast, a study of
CHIKV infection in knockout mice indicated that T cells but not
NK cells play a role in viremia suppression (Poo et al., 2014).
However, the available literature on NK cells in CHIKV infection
is limited.
In the current study, we performed peripheral phenotypic and
functional analyses of T/NK/NKT-like cells from patients in the
acute and convalescent stages of CHIKV infection, to assess the
role of these lymphocytes in CHIK pathogenesis.
Materials and Methods
Study Population
The study population comprised 87 patients from the CHIK
outbreak of September 2011 in Maharashtra, India, and 56
healthy controls from blood donation camps inMaharashtra. The
diagnosis of CHIKVwas based on the presence of IgM antibodies
against the virus (anti-CHIKV IgM) as determined by ELISA
and/or RT-PCR analysis of CHIKV RNA. The control group
consisted of age- and sex-matched healthy individuals negative
for anti-CHIKV IgM/IgG antibodies. Based on the number
of days post-onset of illness (POD), patients were categorized
as acute (POD≤14) or convalescent (POD>14) (Table 1). The
patient groups were comprised of 56 acute and 31 convalescent
patients. The gender ratios (male: female) in the study groups
were as follows: 1.80 for acute, 0.29 for convalescent, and 1.54
for controls. The convalescent patients were symptomatic at the
time of enrolment and were CHIK RNA-negative. The study was
approved by the Institutional Ethical Committee for Research
on Humans, based on the guidelines set by the Indian Council
of Medical Research, New Delhi. Informed written consent was
obtained from all participants.
Serological Testing
All samples were screened by ELISA for anti-CHIKV IgM
and IgG antibodies and for antibodies against dengue virus
(Yergolkar et al., 2006). Only samples that were negative for
dengue virus were included in the study.
Viral Load Quantification
Plasma samples from patients in the acute phase were processed
for quantitation of CHIKV RNA. Briefly, RNA was extracted
using QIAamp viral RNA mini kit (Qiagen, Hilden, Germany)
and the viral load (copies/ml) was determined using primers and
probes based on CHIKV E3, according to a previously described
protocol (Patil et al., 2012).
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TABLE 1 | Characteristics of study population.
Parameters Patients Controls
Acute Convalescent
Study population n = 56 n = 31 n = 56
Sex ratio (Male:Female) 1.80 0.29 1.54
Age (years): median
(range)
38 (13−70) 40(18−82) 27(18−47)
POD: median (range) 12 (2−14) 33 (16−80) NA
Anti-CHIKV IgM Positive, n = 46 Positive Negative
Anti-CHIKV IgG Positive, n = 32 Positive Negative
Viral load(copies/ml):
median (range)
110
(3100−670000000),
n = 23
ND NA
NA, not applicable; ND, not detected; POD, post onset days of illness.
CHIKV Purification and Inactivation by
β-Propiolactone (BPL)
The CHIKV strain (accession number EF027134) used in the
current study was obtained from the virus repository of the
National Institute of Virology, Pune, India. Following incubation
in the Vero E6 cell line, CHIKV was harvested when cells
exhibited 80−90% cytopathic effect. The clarified supernatant
was removed, lysed cell pellets were centrifuged, and the
supernatant was pooled with the culture supernatant. CHIKV
was purified and was subsequently inactivated as previously
described (Kumar et al., 2012). Following protein estimation,
whole, inactivated virus was used as the antigen in the ELISPOT
assay.
Flow Cytometric Analysis
CD3+, CD3+CD4+, and CD3+CD8+ T cell
enumeration
Freshly drawn peripheral blood samples (100µl) from the 45
acute and 31 convalescent patients and the 36 controls were
stained with anti-human CD3 (clone SK7), CD4 (clone RPA-
T4), and CD8 (clone RPA-T8) monoclonal antibodies (BD
Biosciences, CA, USA) as previously described (Tripathy et al.,
2011). The lymphocyte population was distinguished on the
basis of their forward and side scatter properties. Within the
lymphocyte population, the CD3+ T cell population was gated
based on the CD3 staining pattern, whereas the CD3+CD4+and
CD3+CD8+ cells were gated on CD3+ T cells. For each
experiment, 50,000 events were acquired within the lymphocyte
gate and results are expressed as the percentage of positive cells
in the gated population.
NK/NKT-like Cells and their Receptors
Enumeration of NK/NKT-like cells and expression of activation
and inhibitory receptors were investigated in samples from
56 acute and 31 convalescent patients and 56 control
individuals. CD161 and inhibitory receptors were assessed
only in acute patients and controls. Peripheral blood (100µl)
was stained according to a previously described protocol
(Tripathy et al., 2011). The monoclonal antibodies used were
anti-humanCD56 (clone B159), CD3 (clone SK7/UCHT1),
NKp30/NKp44/NKp46/CD244/CD161/NKG2D (clone
p30-15/p44-8/9E2/2-69/DX12/1D11), purchased from BD
Biosciences and CD94 (clone 131412 APC), and NKG2A (clone
131411) purchased from R&D Systems Inc., MN, USA. NK
(CD56+CD3−) and NKT-like (CD56+CD3+) cells were gated
within the lymphocyte population on the basis of their CD56
and CD3 staining pattern; their receptors expression patterns are
expressed as the percentage of gated NK and NKT-like cells.
CFSE-based Cytotoxicity Assay
A carboxyfluorescein succinimidyl ester (CFSE; Invitrogen, NY,
USA)-based cytotoxicity assay was performed in samples from
eight acute patients, six convalescent patients, and eight healthy
controls following a previously described method (Fu et al., 2010;
Das and Tripathy, 2014). Briefly, K562 cells (Target, T) were
labeled with CFSE (0.2µM/106 K562 cells). The cells were washed
and plated in 96-well U-bottom plates and fresh PBMCs (Effector,
E) were added to the target cells at a 10:1 E:T ratio. This was
followed by incubation at 37◦C with 5% CO2 for 6 h. Target cells
treated with 0.1% Triton-X (Sigma, MO, USA) and unlabeled
effector/target cells served as controls. To assess cell lysis, tubes
were kept on ice with 2µg/ml of 7-AAD (BD Biosciences) and
incubated for 5min to label the DNA of the dead cells. This
was followed by immediate acquisition in a BD FACS ARIA II.
During acquisition, 5000 target events were recorded. CFSE+/7-
AAD+ cells were considered to be dead target cells. The readings
for CFSE+/7AAD+cells of target cells were subtracted from the
CFSE+/7-AAD+ cells of the E/T cells for normalization.
%specific killing = [(%experimental target death -
%spontaneous target death)/(100 - %spontaneous target
death)]×100.
Degranulation Assay
Expression of the CD107a marker on NK/NKT-like cells was
quantitated in samples from eight acute patients, six convalescent
patients, and eight healthy controls to assess degranulation
activity, as previously reported (Alter et al., 2004; Das and
Tripathy, 2014). Briefly, PBMCs suspended in RPMI (Invitrogen,
NY, USA) + 10% FBS [effector (E)] were stimulated with MHC
I-devoid K562 cells (ATCC, VA, USA) [target (T)] at a 10:1 (E:T)
ratio along with anti-CD107a (Lamp1)(clone H4A3) antibody
(BD Biosciences) at 37◦C. Culture medium [RPMI medium
supplemented with 10% FBS] alone and PMA (0.25µg/ml) +
ionomycin (0.5µg/ml) (Sigma, MO, USA)-treated PBMCs
served as negative and positive controls, respectively. Following
1 h of stimulation, 4µg/ml of brefeldin A (Sigma, MO, USA)
and 5µg/ml of monensin sodium salt (Sigma, MO, USA) were
added and the cells were incubated for a total of 6 h. Following
incubation, the cells were stained with an anti-human CD56
(clone B159) and CD3 (clone SK7) antibody (BD Biosciences)
cocktail, then washed and fixed in 1% paraformaldehyde. Cells
were gated on NK and NKT-like cells and the CD107a frequency
was evaluated. During acquisition, 5000 events were acquired
within the lymphocyte gate. Data were normalized by subtracting
the readings of unstimulated PBMCs from PBMCs stimulated
with K562 cells.
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Intracellular Cytokines and Perforin Assays
Intracellular cytokine staining and perforin assays were
performed in samples from eight acute patients, six convalescent
patients, and eight healthy controls, as described previously (Fu
et al., 2010; Das and Tripathy, 2014). Following co-incubation
(effector/target) for 6 h, cells were stained with anti-human CD56
(clone B159) and CD3 (clone SK7) monoclonal antibodies (BD
Biosciences) to enumerate the respective cell surface antigens.
The CD3 and CD56 surface-stained cells were permeabilized
for intracellular staining. The monoclonal antibodies, i.e.,
IFN-γ (clone 25723.11)/TNF-α (clone MAb11)/ perforin (clone
δG9) (BD Biosciences) were added to the permeabilized cells,
incubated, washed in BD Perm/Wash buffer (BD Biosciences)
and fixed in paraformaldehyde. Cells were gated on NK and
NKT-like cells. During acquisition, 5000 events were acquired
within the lymphocyte gate.
Acquisition and analysis of the samples was performed in BD
FACS ARIA II using the FACS DIVA software (BD Biosciences).
IFN-γ Elispot Assay
A CHIKV-specific ELISPOT assay for IFN-γ release was
performed on samples from 13 acute and 15 convalescent
patients and was compared with 18 controls, as previously
reported (Tripathy et al., 2011, 2012). PBMCs were isolated
as previously reported (Tripathy et al., 2011). To estimate
the number of CHIKV-specific IFN-γ-secreting spot-forming
cells (SFCs), 1 × 105 PBMCs/well were stimulated with
whole purified and inactivated CHIKV (10µg/ml). In the
positive/negative control wells, cells were stimulated with
10µg/ml of phytohemagglutinin A (Sigma)/medium alone. SFCs
were counted in an ELISPOT reader (Carl Zeiss, Jena, Germany)
using the KS ELISPOT software and were expressed as the
number per 105 cells. The cut-off level for SFCs was set as
the average number of SFCs in the negative control wells.
Results with high background readings or with no PHA response
were excluded. The number of SFCs in unstimulated wells was
subtracted from the number in antigen-stimulated wells in each
subject category for comparison.
Software and Statistical Analysis
Statistical analyses were performed using the SPSS 20 software
(SPSS Inc., IL, USA). Intergroup comparisons were assessed
using a nonparametric Mann–Whitney U-test (where the
difference in variances <4) and a Kolmogorov–Smirnov test
(where the difference in variances >4). The data are expressed as
means (range). P < 0.05 were considered statistically significant.
Spearman’s rank correlation was used to assess the correlation
between NK/NKT-like cells and NKRs with viral load. Only
significant results are shown.
Results
NK (CD56+CD3−) and NKT-like Cell (CD56+CD3+)
Subsets in CHIK Patients
To evaluate the impact of CHIKV infection on the phenotype of
innate immune cells, the percentages of NK and NKT-like cells
from acute and convalescent patients were assessed using flow
cytometry. Higher percentages of NK cells were observed in both
patient groups than in controls [acute: 9.4(0.7−29.2) vs. controls:
8.2(1.4−37.6), p < 0.001 and convalescent: 9.4(3.6−24.6) vs.
controls: 8.2(1.4−37.6), p = 0.001] (Figure 2i). NK cells in
the acute CHIK patients showed a higher absolute count than
in controls [acute: 233(158−270) and controls: 175(101−360),
per mm3] (Supplementary Table 1). The percentage of NKT-
like cells was higher in convalescent patients than in controls
[convalescent: 17.6(0.3−36.6) vs. controls: 7.3(0.15−26.14),
p < 0.001] (Figure 2ii). Among the patient categories, the
percentage of NKT-like cells was higher in convalescent patients
[convalescent: 16.7 (0.3−36.6) vs. acute: 10.2 (0.4−27.2), p =
0.016] (Figure 2ii). Gating strategies for NK and NKT-like cell
enumeration are shown in Figure 2iv.
The correlation between the percentage of NK cells and the
CHIKV load was positive (r = 0.605, p = 0.004) (Figure 2iii).
Representative figures showing the proportion of NK and
NKT-like cells are depicted in (Figure 1ii).
NK Cell Receptor (NKR) Expression on NK Cells
from CHIK Patients
Next, we investigated whether the increased NK cell percentages
were related to changes in expression of activation and inhibitory
receptors. Percentages of NKp30+ NK cells were high in acute
and convalescent patients [acute: 78.72 (0.9−100), convalescent:
80.3 (5.8−99.8) vs. control: 52.3 (2.9−87.8), p = 0.001
for each] (Figure 3Ai). The percentage of NK cells bearing
NKp44+ receptors was high in acute and convalescent patients
[acute: 42 (0−98.9), convalescent: 14.8 (0−96.4) vs. controls:
6.8 (0−5.5), p = 0.025]. The percentage of NKp44+ NK
cells was higher in acute than in convalescent patients (p =
0.008) (Figure 3Aii). The percentage of NKp46+ NK cells
was high in both patient groups compared to controls [acute:
88.69 (6−100), convalescent: 90.5 (67.3−98.5) vs. controls: 71.4
(0−98.1), p = 0.002 for each] (Figure 3Aiii). The percentages
of CD244+ NK cells were higher in both patient categories than
in controls [acute: 70.2 (14.8−100), convalescent: 47.8 (4−100)
vs. controls: 3 (0.1−28.5), p < 0.001 for each]. The percentage
of CD244+ NK cells was higher in acute than in convalescent
patients (p = 0.019) (Figure 3Av). In the same line the mean
fluorescence intensity (MFI) of NKp30+, NKp44+, NKp46+,
and CD244+ NK cells was also high in patient categories than
in controls (Figures 3Bi−iii, v). Among the patient categories,
MFI of NKp44+ NK cells was higher in acute (Figure 3Bii).
Lower percentages of NK cells bearing NKG2D+ receptors were
observed in both patient categories compared to controls [acute:
34.3 (12.6−87.5), convalescent: 32.27 (5.2−85.9)] vs. controls:
83.7 (9.5−100), p < 0.001 for each] (Figure 3Aiv). In consistent
with the percentage of NKG2D+ NK cells, MFI was also lower
in patient categories compared to controls (Figure 3Biv). The
gating strategy used for enumeration of NKRs is shown in
Figure 2iv.
NKRs on NKT-like Cells
The relationship between NKT-like cells and changes in
expression of activation and inhibitory receptors was
investigated. Higher percentages of NKT-like cells bearing
NKp30+ receptors were observed in acute and convalescent
patients [acute: 33.8 (2.3−100), convalescent: 42.8 (1.8−100) vs.
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FIGURE 1 | Percentge of lymphocytes popultion. (i) Upper pannel shows the representative figures for CD3+ T cells proportion in control individuals, acute and
convalescent patients, lower pannel shows representative figures for CD3+CD4+/CD3+CD8+ T cells proportion in control individuals, acute and convalescent
patients. (ii) Shows the representative figures for NK (CD3−CD56+) /NKT-like(CD3+CD56+) cells proportion in control individuals, acute and convalescent patients.
controls: 13.5 (1.6−88.1), p = 0.014 for each] (Figure 3Avii).
The MFI of NKp30+ NKT-like cells were high in acute patients
than in controls, however, comparable among convalescent
patients and controls (Figure 3Bvii). The percentages of
NKp44+ NKT-like cells were higher in acute patients than in
controls [acute: 35.2 (0−96.9) vs. controls: 19.5 (1.6−33.1),
p = 0.001].The percentage of NKp44+ NKT-like cells was higher
in acute than in convalescent patients [acute: 35.2 (0−96.9)
vs. convalescent: 19.6 (0.1−96), p = 0.035] (Figure 3Aviii).
Higher percentages of NKT-like cells bearing CD244+ receptors
were observed in both patient categories [acute: 40.7 (0−100),
convalescent: 25.9 (0−90.5) vs. controls: 0.9 (0−3.3), p < 0.001
for each] (Figure 3Axi). The MFI of NKp44+ and CD244+
NKT-like cells were high in patient categories than in controls
(Figures 3Bviii,xi). Among the patient categories, MFI of
NKp44+ NKT-like cells was high in acute than in controls
(Figure 3Bviii). Percentage of NKp46+ NKT-like cells was
comparable between studied categories (Figure 3Aix) (data
not shown); however, lower MFI was observed in the patient
categories than in controls (Figure 3Bix). Lower percentages of
NKG2D+ NKT-like cells were observed in both patient categories
compared to controls [acute: 39.2 (4.9−93.5), convalescent: 36.2
(9.6−95.8) vs. controls: 81.3 (33.8−98.3), p < 0.001 for each]
(Figure 3Ax). In consistent with the percentage of NKG2D+
NK cells, MFI was also lower in patient categories than in
controls (Figure 3Bx). The percentages of NKT-like cells bearing
CD161+ receptors were higher in acute patients than in controls
[acute: 45.6 (19.7−68.6) vs. controls: 31.6 (12–72.2), p = 0.018].
CD161+ NK/NKT-like cells were not assessed in the convalescent
group (Figures 3Avi,xii). The MFI of CD161+ NKT-like cells
was higher in acute patients, whereas MFI of CD161+ NK cells
was comparable (Figures 3Bvi,xii). The percentages of CD94+
and NKG2A+ NK/NKT-like cells in the acute and control groups
were comparable (data not shown). The gating strategy used for
NKR enumeration is shown in Figure 2iv.
Functional Analysis of NK and NKT-like Cells in
Acute Patients
Effective Cytotoxicity
To assess the correlation between alterations in expression
of activation receptors on NK/NKT-like cells and their
functionality, we performed an effector/target cell based assay.
PBMCs showed significantly higher cytotoxicity activity in acute
CHIK patients than in controls [acute: 4.1 (1.55−8.04) vs.
controls: 1.8 (0−3.73), p = 0.027] (Figure 4i).
Degranulation Assay and Perforin Expression
An effector/target cell based flow cytometry assay was carried out
to assess the expression of CD107a and perforin on NK/NKT-
like cells. A higher percentage of perforin+ NK cells was
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FIGURE 2 | Distribution of NK and NKT-like cells. Percentages of the lymphocytes mentioned were determined from the whole blood of 56 control subjects,
56 acute, and 31 convalescent patients. Box plots show the percentages of (i) NK (CD3−CD56+) cells and (ii) NKT-like (CD3+CD56+) cells. Boxes represent
interquartile ranges, vertical lines represent ranges and horizontal lines represent medians. Nonparametric Kolmogorov–Smirnov test was used for intergroup
comparison. @ denotes A (acute) vs. C(control), # denotes B (convalescent) vs. C (control) and $ denotes A (acute) vs.C (convalescent). p < 0.05 is considered
significant. (iii) Spearman correlation co-efficient shows positive correlation between viral load and NK (CD3−CD56+) cells from acute patients, where p < 0.05
is considered significant and r > 0.5 is considered as positive. (iv) Plots showing the strategy used for gating lymphocyte population, NK and NKT-like cells.
Lymphocytes are gated in FSC vs. SSC plot, upper left quadrant (Q1) of contour plot shows NK cells (CD3−CD56+) and upper right quadrant (Q2) shows
NKT-like cells (CD56+CD3+). NK/NKT-like cells were gated within the lymphocytes as per CD56 and CD3 staining pattern and NKRs were gated on
NK/NKT-like cells individually. Histogram plots represent the percentage of NKRs+ (NK receptors) NK/NKT-like cells.
FIGURE 3 | Patterns of NK receptors (NKRs) on NK and NKT-like cells. Frequencies of NKRs were enumerated from the whole blood of 30 control
subjects, 30 acute, and 31 convalescent patients. (A) Box plots (i-vi) show percentages of NKRs+ NK (CD3−CD56+) cells as (i) NKp30, (ii) NKp44, (iii)
NKp46, (iv) NKG2D, (v) CD244, (vi) CD161. Box plots (vii–xii) shows FACS analysis of percentages of NKRs+ NKT-like (CD3+CD56+) cells as (vii) NKp30,
(viii) NKp44, (ix) NKp46, (x) NKG2D, (xi) CD244, (xii) CD161. CD161 percentage was enumerated in acute patients and controls. (B) Box plots show mean
fluorescence intensity (MFI) of NKRs+ NK cells (i–vi) and NKRs+ NKT-like cells (vii–xii). Kolmogorov–Smirnov test was used for intergroup comparison.
p < 0.05 is considered significant.
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FIGURE 4 | Cytotoxic potential, intracellular perforin and cytokine expression of NK/NKT-like cells against target cells (K562). PBMCs (effector) were
isolated from the whole blood of eight control subjects, eight acute patients, and six convalescent patients. PBMCs were co-cultured with K562 cells (target) at an
effector/target ratio of 10:1 for 6 h. Box plots show, (i) % specific killing against target cells, (ii) perforin expression by NK cells, (iii) perforin expression by NKT-like cells,
(iv) IFN-γ by NK cells, and (v) IFN-γ by NKT-like cells. Mann–Whitney U-test/Kolmogorov–Smirnov test was used for intergroup comparison. p < 0.05 is considered
significant.
observed in the acute CHIK group than in the control and
convalescent groups [acute: 45.4 (20.3−63.8), vs. control: 26.4
(4.4−42) and vs. convalescent: 12 (1−63), p = 0.046 and
0.039 respectively] (Figure 4ii). A lower percentage of perforin+
NK cells was observed in the convalescent group than in
the control group [control: 26.4 (4.4−42) vs. convalescent:
12 (1−63), p = 0.023] (Figure 4ii). The percentage of
perforin+ NKT-like cells was comparable among the groups
(data not shown). CD107a expression on NK and NKT-like
cells was comparable among the studied groups (Figure 4iii)
(data not shown). However, the MFI of CD107a+ NK cells
from acute CHIK patients was higher than in controls
(Supplementary Figure 1).
Intracellular Cytokines (IFN-γ and TNF-α)
To evaluate the impact of CHIKV infection on the cytokine
production capacity of NK/NKT-like cells, we performed
intracellular cytokine staining and the percentages of positive
cells were enumerated using flow cytometry. A Kolmogorov–
Smirnov test showed that IFN-γ expression was higher on
NKT-like cells of acute CHIK patients than in controls
[acute: 2.8 (0.1-6.9) vs. controls: 0.2 (0.1−0.4), p = 0.042)]
(Figure 4v). Higher expression of IFN-γ was also observed on
NK [convalescent: 3.1 (1.3−8.2) vs. controls: 0.2 (0.1-0.5), p =
0.009)] and NKT-like [convalescent: 2.1 (0.8−4.8) vs. controls:
0.2 (0.1−0.4), p = 0.009)] cells of the convalescent group
compared to the control group (Figures 4iv,v). TNF-α expression
was comparable between all groups (data not shown).
Peripheral T Lymphocyte Subsets in CHIK
Patients
To investigate the impact of CHIKV infection on the phenotypes
of T cells, percentages of CD3+, CD3+CD4+, and CD3+CD8+
T cells were enumerated using flow cytometry of samples from
acute and convalescent patients. Lower percentages of both
CD3+and CD3+CD8+ T cells were observed in acute patients
than in controls [CD3+: acute, 48.7 (22.9−74.3) vs. controls, 63.4
(49.1−79.3), p < 0.001 and CD3+CD8+: acute, 32.3 (10.4−98.2)
vs. controls, 38.01 (14.6−63), p = 0.013] (Figures 5i,iii). A
lower absolute count of both CD3+ [acute: 831 (250−1639)
and controls: 1519 (1157−1822), per mm3] and CD3+CD8+ T
cells [acute: 471 (226−669) and controls: 934 (724−1180), per
mm3] was observed in acute CHIK patients than in controls
(Supplementary Table 1). The percentage of CD3+CD4+T cells
was higher in both patient groups than in controls [CD3+CD4+:
acute, 52.2 (23−92.6) vs. controls, 46.1 (26.7−66.1), p = 0.02
and convalescent, 58.8 (41.4−86.6) vs. controls, 46.1 (26.7−66.1),
p < 0.001] (Figure 5ii). The percentages of CD3+, CD3+CD4+,
and CD3+CD8+T cells were higher in convalescent than in acute
[CD3+: acute, 48.7 (22.9−74.3) vs. convalescent, 60.7 (10.−77.8),
p = 0.003; CD3+CD4+: acute, 52.2 (23−92.6) vs. convalescent,
58.8 (41.4−86.6), p = 0.032 and CD3+CD8+: acute, 32.3
(10.4−98.2) vs. convalescent: [35.3 (2.72−69.7), p = 0.032]
(Figures 5i–iii). Gating strategies for CD3+, CD3+CD4+, and
CD3+CD8+ T cell enumeration are shown in Figure 5iv. The
data are represented as means (range).
Representative figures for T lymphocyte subsets proportion
are depicted in Figure 1i.
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FIGURE 5 | Distribution of CD3+, CD3+CD4+ and CD3+CD8+ T cells. Percentages of the lymphocytes mentioned were determined from the whole
blood of 36 control (represented by “C”) subjects, 45 acute (represented by “A”), and 31 convalescent (represented by “B”) patients. Box plots show the
percetage of (i) CD3+ T cells, (ii) CD3+CD4+ T cells, and (iii) CD3+CD8+ T cells. Kolmogorov–Smirnov test was used for intergroup comparison. p < 0.05
is considered significant. (iv) Plots showing the strategy used for gating lymphocytes, CD3+ T, CD3+CD4+ T, and CD3+CD8+ T cells. Lymphocytes are
gated in FSC vs. SSC plot, CD3+ T cells were gated within the lymphocytes population, CD3+CD4+ and CD3+CD8+ T cells were gated on CD3+ T
cells. Contour plot shows CD3+ T cell gating, upper left quadrant (Q1) of the contour plot shows CD3+CD4+ T cells and lower right quadrant (Q4)
shows CD3+CD8+ T cells.
CHIKV-specific IFN-γ Release in Elispot
To determine the CHIKV-specific IFN-γ response, we performed
an ELISPOT assay using whole CHIKV virus particles as
antigens. In the control group (n = 18), the IFN-γ responses
in unstimulated, CHIKV-stimulated, and PHA-stimulated cells
were 1 (0−6), 2 (0−13), and 113 (25−248) SFCs/105 cells,
respectively. In the acute patient group (n = 13), the
IFN-γ responses in unstimulated, CHIKV-stimulated, and
PHA-stimulated cells were 36 (18−61), 41 (22−70), and 165
(52−390), respectively. In the convalescent group (n = 15),
the corresponding figures were 36 (15−58), 53 (20−148), and
152 (31−339). IFN-γ responses in unstimulated cells of both
patient groups were higher than in controls (Figure 6). IFN-
γ spots in the antigen-stimulated wells for the control, acute,
and convalescent groups were 1 (0−8), 7 (0−22), and 20
(0−107), respectively, after subtracting the average number of
spots in unstimulated wells from antigen-stimulated wells in
each category. CHIKV-specific IFN-γ responses were higher in
the convalescent group than in the control group (p = 0.016)
(Figure 6).
Discussion
The type I interferon production and NK cell expression in
patients in the early phase of CHIKV infection indicated the
involvement of innate immune responses to CHIKV infection
(Her et al., 2010; Petitdemange et al., 2011). Therefore, a detailed
investigation of NK and NKT-like cell activities was undertaken
in a transverse study from a CHIK outbreak, to explore the
interplay between innate and adaptive responses in CHIKV
infection.
The lower percentages of CD3+CD8+ and CD3+ T cells
observed in the acute patient group were concordant with the
reported decrease in the percentage of CD3+ T cells in CHIKV-
infected patients and supports the hypothesis of infection-
associated profound T cell lymphopenia (Petitdemange et al.,
2011). The down regulation of both T cell populations could
be a transient phenomenon, as shown by the comparable
values observed in controls and convalescent patients. However,
there are reports of high levels of CD8+ T cells in acute
patients (Hoarau et al., 2010; Wauquier et al., 2011). The
difference in the results may be related to the large differences
in sample size/the differences in the cluster of differentiation
(CD) markers used/differences in the immune response of the
two geographically different populations studied. A study using
a mouse model indicated that CD8+ T cells play no role in
the antiviral response or pathology of CHIKV infection. The
higher levels of CD3+CD4+ T cells observed in the current
patient population could account for the joint swelling observed,
as reported in a study using a mouse model (Teo et al.,
2013).
The positive correlation observed between the percentage
of NK cells and the CHIKV load is concordant with the
observations of Petitdemange et al. suggesting the involvement of
NK cells from the inception of CHIKV infection (Petitdemange
et al., 2011).
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FIGURE 6 | IFN-γ responses by ELISPOT. Box plots are showing IFN-γ
responses by PBMCs from 18 control subjects, 13 acute, and 15
convalescent patients, stimulated with CHIK antigen (inactivated CHIKV
10µg/106 PBMCs). Y axis is showing spot forming cells (SFCs) per 105 million
cells. Plot shows IFN-γ responses by unstimulated PBMCs before subtraction
from stimulated PBMCs well (spontaneous IFN-γ production) and after
subtraction of spots in unstimulated PBMCs well from stimulated well (CHIKV
specific IFN-γ production). Non-parametric Kolmogorov–Smirnov test was
used for intergroup comparison. p < 0.05 is considered significant.
The function of NK cells is tightly orchestrated by a
balance between signals derived from inhibitory and activation
receptors (Cooper et al., 2001; De Maria et al., 2011). Activation
receptors, i.e., NKG2C, NKG2D, and DNAM-1, and natural
cytotoxicity receptors, i.e., NKp46, NKp44, and NKp30, along
with various co-stimulatory receptors are involved in human
NK cell activation (Moretta et al., 2001; Lanier, 2005). Reports
that higher expression of the activation receptors NKp30,
NKp44, NKp46, and CD244 and lower levels of the inhibitory
receptors NKG2A and CD94 on NK cells produce an effective
cytotoxic response are concordant with the results observed in
the acute patient population studied here (Biron et al., 1999;
De Maria et al., 2001; Lanier, 2005). Corroborating these data,
higher MFI of CD107a+ NK cells in the acute patients than
in controls suggests that, the degranulation capacity per NK
cell in the acute CHIKV patients is higher. In a similar line,
Srivastava et al. have demonstrated comparable cytotoxic activity
against K562 cells in PBMCs in acute Hepatitis E patients
regardless of lower NK cells percentage. This phenomenon has
been attributed to a greater cytotoxic potential per cell of the
PBMCs from acute patients (Srivastava et al., 2008). Higher
expression of NKp44 and lower levels of NKG2A, NKp30, and
NKp46, associated with cytotoxic NK cells, has been reported in
Gabonese CHIK patients (Petitdemange et al., 2011). Hershkovitz
et al. demonstrated a direct protein-protein interaction between
Flavivirus E protein and NKp44 that triggers the secretion of
granules contained in NK cells, suggesting NKp44-mediated
NK cytotoxic activity (Hershkovitz et al., 2009). Similarly, the
higher percentage of NKp44+ NK/NKT-like cells and the higher
cytotoxic potential of NK cells observed in acute CHIK patients
suggest that NKp44-CHIKV protein interaction studies would
be useful. The higher expression of NKp44+ NK cells observed
in CHIK patients could be indicative of the activation of
NK cells in CHIKV infection, irrespective of their replicative
status. NKp46+ NK cells in acute patients might modulate
cytotoxicity, as reported in other viral infections (Mandelboim
et al., 2001; Krämer et al., 2012). A lower level of CD244+
(2B4) expression has been correlated with impaired cytotoxic
and IFN-γ-producing activities of NK cells (Marcoe et al., 2012).
Reverse observation of the current data indicates CD244+ as
a mediator for NK/NKT-like cell activation. CD244+-mediated
signaling can contribute both positively and negatively to viral
clearance and immune-mediated disease (Marcoe et al., 2012).
An understanding of how CD244 regulates both effector cell
function and NK/T cell crosstalk may offer opportunities to
define the roles of subsets of NK cells in early CHIKV infection.
Lower expression of NKG2D+ NK/NKT-like cells observed
here and in herpes virus infection suggests that NKG2D+
cells contribute little to activation status (Jonjic et al., 2008;
Muntasell et al., 2010). However, Petitdemange et al. have shown
a functional NK cells in spite of comparable NKG2D expression
on NK cells in CHIK patients (Petitdemange et al., 2011). The
higher expression of CD161+ NKT-like cells observed in acute
patients suggests the need for further exploration. The elevation
in activation receptors observed in the current patient population
could be responsible for NK cell proliferation and might play a
role in NK cell maintenance during infection and may deliver
direct antiviral effects, as previously reported (Vidal et al., 2011).
The functionality of NK cells requires the differential
engagement of cell surface receptors in combination with
activities mediated by pro-inflammatory cytokines. The higher
IFN-γ expression observed on NKT-like cells of acute CHIK
patients leads us to hypothesize that NKT-like cells play an
immune regulatory role toward the cytotoxicity of NK cells.
The IFN-γ release observed in the ELISPOT assay and the
IFN-γ expression observed on both NK/NKT-like cells in the
convalescent stage are suggestive of the key roles played by
these cells in the development of an effective adaptive immune
response. In contrast to the reported role of perforin in an
alphavirus-infected mouse model, the higher perforin expression
observed on NK cells of acute patients suggested that cytotoxicity
could be perforin-mediated phenomena (Kägi and Hengartner,
1996).
It may be a coincidence that our current study population
from the recent CHIK outbreak containedmoremale than female
individuals. Further, statistical analyses of each assay parameter
following separation by gender were comparable to the pooled
results, suggesting that the data were not influenced by the gender
ratio.
Finally, we showed that, during acute CHIKV infection,
NK cells are cytotoxic (perforin), and that NKT-like cells
elicited an effector response (IFN-γ expression) followed
by an adaptive response (IFN-γ release in the ELISPOT
assay and IFN-γ expression on NK/NKT-like cells) in the
convalescent phase. The heightened cytotoxicity and comparable
effector functions of NK cells suggested a dichotomy of
NK cells in acute CHIKV infection. The present study
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elucidates the potential role of activation receptors on cytotoxic
NK cells in influencing the pathogenesis of early CHIKV
infection. Further, study of the molecular mechanisms that
limit viral dissemination/establishment of chronic disease will
aid in understanding how NK/NKT-like cells control CHIKV
infection.
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Supplementary Figure 1 | CD107a expression by NK and NKT-like cells
against target (K562) cells. PBMCs (effector) were isolated from the whole
blood of 8 control subjects, 8 acute patients, and 6 convalescent patients.
PBMCs were co-cultured with target cells at an effector/target ratio of 10:1 for 6 h.
@ denotes A (acute) vs. C(control), # denotes B (convalescent) vs. C (control) and
$ denotes A (acute) vs.C (convalescent). (A) Box plots are showing the
percentage of CD107a+ (i) NK cells and (ii) NKT-like cells. (B) Box plots are
showing the mean fluorescence intensity (MFI) of CD107a+ (i) NK cells and (ii)
NKT-like cells. Kolmogorov–Smirnov test was used for intergroup comparison.
p < 0.05 is considered significant.
Supplementary Table 1 | Absolute count of CD3+, CD3+CD4+,
CD3+CD8+, CD3−CD56+, and CD3+CD56+ cells from the whole blood of
CHIKV infected patients.
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